LeMaitre Vascular

LeMaitre Vascular

Yahoo Finance • 7 days ago

1 of Wall Street’s Favorite Stocks to Own for Decades and 2 We Brush Off

1 of Wall Street's Favorite Stocks to Own for Decades and 2 We Brush Off Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it's worth remembering that... Full story

Yahoo Finance • 22 days ago

2 Profitable Stocks to Target This Week and 1 We Ignore

2 Profitable Stocks to Target This Week and 1 We Ignore Even if a company is profitable, it doesn't always mean it's a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their fu... Full story

Yahoo Finance • last month

3 Out-of-Favor Stocks with Questionable Fundamentals

3 Out-of-Favor Stocks with Questionable Fundamentals The past year hasn't been kind to the stocks featured in this article. Each has tumbled to its lowest point in 12 months, leaving investors to decide whether they're witnessing fire sal... Full story

Yahoo Finance • last month

Speculative Rally Weighed on LeMaitre Vascular (LMAT)

Riverwater Partners, an investment management company, released its 'Small Cap Strategy' Q2 2026 investor letter. The letter can be downloaded here. The Small Cap Strategy underperformed the Russell 2000 in the second quarter as the benchm... Full story

Yahoo Finance • 2 months ago

LeMaitre Vascular (LMAT) Hit by Profit Taking

Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 In... Full story

Yahoo Finance • 2 months ago

LeMaitre Q2 2026 Financial Results

LeMaitre Vascular, Inc. BURLINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2026 results, announced a quarterly dividend of... Full story

Yahoo Finance • 2 months ago

LeMaitre (LMAT) Reports Earnings Tomorrow: What To Expect

LeMaitre (LMAT) Reports Earnings Tomorrow: What To Expect Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be announcing earnings results this Tuesday after market close. Here's what you need to know. LeMaitre met analysts' re... Full story

Yahoo Finance • 4 months ago

3 of Wall Street’s Favorite Stocks We Find Risky

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about com... Full story

Yahoo Finance • 5 months ago

1 Reason to Avoid LMAT and 1 Stock to Buy Instead

LeMaitre has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 15.5% to $101.53 per share while the index has gained 11.3%. Is now the time to buy LeMaitre, or s... Full story

Yahoo Finance • 5 months ago

3 Healthcare Stocks with Open Questions

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The r... Full story

Yahoo Finance • 5 months ago

LeMaitre to Present at the Bank of America Healthcare Conference

BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that management will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026, at 5:15 PM PT. About LeMait... Full story

Yahoo Finance • 6 months ago

Lemaitre Vascular (LMAT) is Strengthening Profitability in Vascular Disease Treatment

Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The first quarter of 2026 began with optimism about the domestic economy and attractive... Full story

Yahoo Finance • 6 months ago

Mid-cap healthcare stocks with A grade EPS revisions ahead of earnings

[Heart Health Concept] Eoneren/E+ via Getty Images As Q1 2026 earnings season approaches, the healthcare sector enters reporting season as one of the market's primary laggards, with the Health Care Select Sector SPDR Fund (XLV [https://se... Full story

Yahoo Finance • 6 months ago

Is LeMaitre Vascular, Inc. (LMAT) A Good Stock To Buy Now?

Is LMAT a good stock to buy? We came across a bullish thesis on LeMaitre Vascular, Inc. on FluentInQuality’s Substack. In this article, we will summarize the bulls’ thesis on LMAT. LeMaitre Vascular, Inc.'s share was trading at $110.33 as... Full story

Yahoo Finance • 7 months ago

A LeMaitre Vascular (LMAT) Insider Sold 2,625 Shares for $285K

On March 11, 2026, LeMaitre Vascular(NASDAQ:LMAT) Senior Vice President, Operations, Trent G Kamke, reported the exercise and immediate sale of 2,625 shares of common stock for total proceeds of approximately $285,000, according to this SE... Full story

Yahoo Finance • 7 months ago

Artivion, Intuitive Surgical, GE HealthCare, LeMaitre, and Globus Medical Shares Plummet, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and poli... Full story

Yahoo Finance • 7 months ago

3 Unpopular Stocks We’re Skeptical Of

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth. Whatever the... Full story

Yahoo Finance • 7 months ago

3 Healthcare Stocks We’re Skeptical Of

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six... Full story

Yahoo Finance • 7 months ago

2 Profitable Stocks with Exciting Potential and 1 We Turn Down

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity". Profits are valuable, b... Full story

Yahoo Finance • 7 months ago

LeMaitre Vascular, Inc. (LMAT): A Bull Case Theory

We came across a bullish thesis on LeMaitre Vascular, Inc. on Compounding Quality’s Substack. In this article, we will summarize the bulls’ thesis on LMAT. LeMaitre Vascular, Inc.'s share was trading at $87.78 as of Feb. LMAT’s trailing an... Full story